BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21860567)

  • 1. Clinical features of idiopathic juxtafoveal telangiectasis in Koreans.
    Lee SW; Kim SM; Kim YT; Kang SW
    Korean J Ophthalmol; 2011 Aug; 25(4):225-30. PubMed ID: 21860567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of macular edema in idiopathic juxtafoveal telangiectasis using PDT.
    Kotoula MG; Chatzoulis DZ; Karabatsas CH; Tsiloulis A; Tsironi EE
    Ophthalmic Surg Lasers Imaging; 2009; 40(1):65-7. PubMed ID: 19205501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis.
    Alldredge CD; Garretson BR
    Retina; 2003 Feb; 23(1):113-6. PubMed ID: 12652245
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of intravitreal triamcinolone acetonide injection in unilateral idiopathic juxtafoveal telangiectasis.
    Li KK; Goh TY; Parsons H; Chan WM; Lam DS
    Clin Exp Ophthalmol; 2005 Oct; 33(5):542-4. PubMed ID: 16181291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic juxtafoveolar retinal telangiectasis: clinical pattern in 19 cases.
    Abujamra S; Bonanomi MT; Cresta FB; Machado CG; Pimentel SL; Caramelli CB
    Ophthalmologica; 2000; 214(6):406-11. PubMed ID: 11054001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravitreal triamcinolone injection in the treatment of idiopathic juxtafoveal telangiectasis].
    Maia OO; Takahashi WY; Bonanomi MT; Nascimento VP; Melo CS
    Arq Bras Oftalmol; 2006; 69(6):941-4. PubMed ID: 17273694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of idiopathic juxtafoveolar retinal telangiectasis with bevacizumab (avastin)].
    Schulze S; Mennel S
    Klin Monbl Augenheilkd; 2007 Oct; 224(10):787-90. PubMed ID: 17952823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.
    Potter MJ; Szabo SM; Chan EY; Morris AH
    Am J Ophthalmol; 2002 Jan; 133(1):149-51. PubMed ID: 11755857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis.
    Park DW; Schatz H; McDonald HR; Johnson RN
    Ophthalmology; 1997 Nov; 104(11):1838-46. PubMed ID: 9373114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography.
    Paunescu LA; Ko TH; Duker JS; Chan A; Drexler W; Schuman JS; Fujimoto JG
    Ophthalmology; 2006 Jan; 113(1):48-57. PubMed ID: 16343625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.
    Rishi P; Rishi E; Shroff D
    Indian J Ophthalmol; 2009; 57(3):241-2. PubMed ID: 19384026
    [No Abstract]   [Full Text] [Related]  

  • 12. Idiopathic juxtafoveal retinal telangiectasia.
    Wu J; Ferrucci S
    Optometry; 2008 Nov; 79(11):653-62. PubMed ID: 19811762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic juxtafoveal retinal telangiectasis: case report and literature review.
    Sindt SJ; Oh K
    Optometry; 2001 Apr; 72(4):228-33. PubMed ID: 11338447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.
    Smithen LM; Spaide RF
    Am J Ophthalmol; 2004 Nov; 138(5):884-5. PubMed ID: 15531339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Optical coherence tomography findings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis.
    Querques G; Delle Noci N
    Retina; 2008 Feb; 28(2):368-9; author reply 369-70. PubMed ID: 18301049
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravitreal bevacizumab therapy for idiopathic macular telangiectasia.
    Matsumoto Y; Yuzawa M
    Jpn J Ophthalmol; 2010 Jul; 54(4):320-4. PubMed ID: 20700800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different treatment modalities for choroidal neovascularization in two eyes of one patient with bilateral type 2A parafoveal telangiectasia.
    Dave V; Chhablani J; Narayanan R
    Indian J Ophthalmol; 2013 Jul; 61(7):353-5. PubMed ID: 23571237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.
    Arevalo JF; Sanchez JG; Garcia RA; Wu L; Berrocal MH; Rodriguez FJ; Rodríguez A; Novoa LA; Garcia-Amaris R
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1673-80. PubMed ID: 17619895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.
    Snyers B; Verougstraete C; Postelmans L; Leys A; Hykin P
    Am J Ophthalmol; 2004 May; 137(5):812-9. PubMed ID: 15126144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular edema associated with latanoprost use in a patient with idiopathic juxtafoveal retinal telangiectasis.
    Baba T; Nagayama M; Ohtsuki H; Hirooka K; Shiraga F
    Jpn J Ophthalmol; 2008; 52(1):68-70. PubMed ID: 18369705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.